Drug
Estradiol/norethindrone Acetate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Breast Cancer Female | 191 | 78.1 | 86.6 | signal |
| 2 | Breast Cancer Metastatic | 44 | 45.0 | 46.0 | signal |
| 3 | Breast Cancer | 281 | 32.7 | 38.2 | signal |
| 4 | Bursitis | 20 | 18.1 | 18.3 | signal |
| 5 | Body Temperature Decreased | 16 | 17.6 | 17.8 | signal |
| 6 | Brain Fog | 20 | 15.0 | 15.1 | signal |
| 7 | Hypokinesia | 17 | 12.8 | 12.9 | signal |
| 8 | Bone Density Decreased | 32 | 11.0 | 11.2 | signal |
| 9 | Menorrhagia | 20 | 11.0 | 11.1 | signal |
| 10 | Blood Pressure Systolic Increased | 19 | 10.6 | 10.7 | signal |
| 11 | Middle Insomnia | 18 | 10.6 | 10.7 | signal |
| 12 | Deformity | 9 | 10.5 | 10.5 | signal |
| 13 | Breast Pain | 10 | 10.3 | 10.3 | signal |
| 14 | Product Administration Error | 18 | 9.9 | 9.9 | signal |
| 15 | Vaginal Haemorrhage | 35 | 9.0 | 9.1 | signal |
| 16 | Abnormal Dreams | 21 | 8.3 | 8.3 | signal |
| 17 | Abdominal Pain Lower | 18 | 7.8 | 7.8 | signal |
| 18 | Micturition Urgency | 8 | 7.7 | 7.7 | signal |
| 19 | Hot Flush | 51 | 7.4 | 7.6 | signal |
| 20 | Heart Rate Decreased | 23 | 7.1 | 7.2 | signal |
| 21 | Dental Caries | 7 | 6.9 | 6.9 | signal |
| 22 | Blood Potassium Decreased | 19 | 6.9 | 7.0 | signal |
| 23 | Obesity | 9 | 6.2 | 6.2 | signal |
| 24 | Tooth Fracture | 6 | 5.9 | 6.0 | signal |
| 25 | Nerve Compression | 5 | 5.9 | 5.9 | signal |
| 26 | Joint Injury | 11 | 5.6 | 5.6 | signal |
| 27 | Poor Quality Sleep | 11 | 5.6 | 5.6 | signal |
| 28 | Vitreous Floaters | 5 | 5.6 | 5.6 | signal |
| 29 | Gingival Bleeding | 7 | 5.6 | 5.6 | signal |
| 30 | Pneumocystis Jirovecii Pneumonia | 5 | 5.5 | 5.5 | signal |
| 31 | Pelvic Pain | 9 | 5.4 | 5.4 | signal |
| 32 | Secretion Discharge | 6 | 5.3 | 5.3 | signal |
| 33 | Thyroid Disorder | 7 | 5.0 | 5.0 | signal |
| 34 | Drug Dispensing Error | 7 | 4.9 | 4.9 | signal |
| 35 | Hypertensive Crisis | 5 | 4.9 | 4.9 | signal |
| 36 | Tooth Disorder | 10 | 4.9 | 4.9 | signal |
| 37 | Blood Thyroid Stimulating Hormone Increased | 4 | 4.7 | 4.7 | signal |
| 38 | Ovarian Cancer | 4 | 4.7 | 4.7 | signal |
| 39 | Skin Reaction | 6 | 4.7 | 4.7 | signal |
| 40 | Blood Pressure Fluctuation | 10 | 4.5 | 4.6 | signal |
| 41 | Metrorrhagia | 7 | 4.4 | 4.4 | signal |
| 42 | Application Site Irritation | 5 | 4.4 | 4.4 | signal |
| 43 | Vaginal Discharge | 4 | 4.3 | 4.4 | signal |
| 44 | Bone Loss | 6 | 4.3 | 4.3 | signal |
| 45 | Dry Throat | 4 | 4.3 | 4.3 | signal |
| 46 | Needle Issue | 11 | 4.2 | 4.2 | signal |
| 47 | Dysmenorrhoea | 5 | 4.2 | 4.2 | signal |
| 48 | Drug Administered At Inappropriate Site | 4 | 4.1 | 4.1 | signal |
| 49 | Back Disorder | 6 | 4.0 | 4.0 | signal |
| 50 | Lip Swelling | 12 | 3.9 | 4.0 | signal |
| 51 | Intestinal Perforation | 4 | 3.9 | 3.9 | signal |
| 52 | Local Swelling | 6 | 3.7 | 3.7 | signal |
| 53 | Abnormal Weight Gain | 4 | 3.5 | 3.5 | signal |
| 54 | Breast Cancer Stage I | 3 | 3.5 | 3.5 | no signal |
| 55 | Abortion Induced | 3 | 3.5 | 3.5 | no signal |
| 56 | Application Site Erythema | 8 | 3.3 | 3.3 | signal |
| 57 | Angioedema | 13 | 3.2 | 3.2 | signal |
| 58 | Akathisia | 4 | 3.2 | 3.2 | signal |
| 59 | Emotional Disorder | 9 | 3.2 | 3.2 | signal |
| 60 | Application Site Rash | 4 | 3.2 | 3.2 | no signal |
| 61 | Bipolar Disorder | 3 | 3.0 | 3.0 | no signal |
| 62 | Pharmaceutical Product Complaint | 7 | 2.9 | 2.9 | signal |
| 63 | Madarosis | 3 | 2.8 | 2.8 | no signal |
| 64 | Product Adhesion Issue | 9 | 2.8 | 2.8 | signal |
| 65 | Acne | 18 | 2.6 | 2.6 | signal |
| 66 | Product Dispensing Error | 5 | 2.5 | 2.5 | no signal |
| 67 | Product Substitution Issue | 13 | 2.5 | 2.5 | signal |
| 68 | Osteonecrosis Of Jaw | 5 | 2.2 | 2.2 | no signal |
| 69 | Incorrect Drug Administration Duration | 4 | 1.5 | 1.5 | no signal |
| 70 | Application Site Pruritus | 3 | 1.4 | 1.4 | no signal |
| 71 | Multiple Sclerosis Relapse | 9 | 1.4 | 1.4 | no signal |
| 72 | Injection Site Mass | 4 | 1.2 | 1.2 | no signal |
| 73 | Drug Withdrawal Syndrome | 8 | 1.0 | 1.0 | no signal |